
Press 2018
Nov 08, 2018 |
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
|
Nov 08, 2018 |
Biostage Reports 2018 Third Quarter Financial Results
|
Nov 07, 2018 |
Ms. Ting Li Appointed to Biostage Board of Directors
|
Nov 06, 2018 |
Biostage awarded $1.1 million Phase II NIH SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for pediatric esophageal atresia
|
Nov 02, 2018 |
Biostage to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Operations
|
Aug 14, 2018 |
Biostage Reports 2018 Second Quarter Financial Results
|
Aug 09, 2018 |
Biostage to Host Conference Call to Discuss Second Quarter 2018 Financial Results and Operations
|
May 31, 2018 |
Biostage Closes $3.6 Million Private Placement at a price of $3.60 per share
|
May 31, 2018 |
Hong Yu Appointed President of Biostage
|
May 25, 2018 |
Dr. Wei Zhang Elected to Biostage's Board of Directors
|
May 10, 2018 |
Biostage Reports 2018 First Quarter Financial Results
|
May 04, 2018 |
Biostage to Host Conference Call to Discuss First Quarter 2018 Financial Results and Operations
|
Apr 02, 2018 |
Biostage Reports 2017 Financial Results
|
Mar 29, 2018 |
Biostage Names Distinguished Children's Hospital Executive James Shmerling to its Board of Directors
|
Mar 29, 2018 |
Biostage awarded SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients
|
Mar 13, 2018 |
Biostage Preclinical Study Results Published in New Report
|
Feb 20, 2018 |
Biostage Closes $1 Million Private Placement
|
Feb 20, 2018 |
Biostage Appoints to its Scientific Advisory Board Charles S. Cox, Jr., MD
|
Feb 12, 2018 |
Biostage Appoints to its Scientific Advisory Board Charles S. Cox, Jr., MD
|
Feb 12, 2018 |
Biostage, Inc. Names Jason Chen Chairman of its Board of Directors
|
Feb 06, 2018 |
Biostage to Host Conference Call to Provide Business Update
|
Jan 31, 2018 |
Biostage Appoints to its Scientific Advisory Board Christine Finck, MD, Executive Vice President, Surgeon-in-Chief at Connecticut Children's Medical Center
|
Jan 03, 2018 |
Biostage Closes $4.2 Million Private Placement
|